Sign in

CIK 0001680581 · Non-accelerated filer<br>Smaller reporting company

Fulcrum Therapeutics, Inc.

Sign in to watch
Ticker
FULC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
474839948
Phone
617-651-8851
Business address
26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
  1. 4 Open-market sale Director sold 15,000 shares at $11.87 ($178,089)
  2. 4 Open-market sale Chief Legal Officer sold 3,452 shares at $12.92 ($44,600)
  3. 4 Open-market sale 10% owner sold 4,175,139 shares at an average $13.98 ($58,377,021)
  4. 4 Open-market sale Director sold 15,000 shares at $11.03 ($165,495)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Open-market sale Principal Accounting Officer sold 498 shares at $5.06 ($2,520)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 2 of 12 · 221 filings